Dr. Gaveras holds the position of Chief Psychiatrist at Talkiatry. She is board certified in child, adolescent and adult psychiatry as well as in addiction medicine and has been practicing for over 17 years.
Dr. Gaveras’ practice focuses on medication management. Typically she offers this in conjunction with supportive or emotionally focused therapy in 30 minute follow-up visits. Occasionally Dr. Gaveras may believe that additional therapy is also needed and ask that you bring a therapist into your care team to provide the best outcome.
She received her medical degree from the University of New England College of Osteopathic Medicine in Biddeford, ME before moving back to NY to complete her residency at the SUNY Downstate Medical Center and fellowship in child and adolescent psychiatry at St. Luke’s – Roosevelt Hospital. After completing training, she remained and worked with dual diagnosed adolescents at the Comprehensive Rehabilitation and Education Service (CARES) before becoming the Director of Training and Education for the Mount Sinai St. Luke’s and Roosevelt Hospitals. She was then the associate director of child and adolescent emergency psychiatry at Cohen Children’s Medical Center before becoming the Director of the Comprehensive Psychiatric Emergency Program (CPEP) at Kings County Hospital in Brooklyn.
Dr. Gaveras has held academic appointments at Columbia University College of Physicians and Surgeons, Mount Sinai Icahn School of Medicine, Touro College of Osteopathic Medicine, Zucker School of Medicine, and SUNY Downstate Medical College. She has appeared in numerous professional publications and authored several research papers.
In addition to general and child and adolescent psychiatry, Dr. Gaveras is also board certified in addiction medicine and trained in the Eating Disorders, Compulsions and Addictions Service (EDCAS) at the William Alanson White Institute. She completed her undergraduate studies at New York University. While having treated a wide variety of patients, her primary clinical focus has been in the treatment of adolescents and young adults with co-occuring substance use disorders.